NAFDAC Raises Alarm Over Recall of Children’s Ibuprofen in US, Warns Nigerians

NAFDAC Raises Alarm Over Recall of Children’s Ibuprofen in US, Warns Nigerians

  • NAFDAC has warned of contaminated Children’s Ibuprofen Oral Suspension following a US recall over safety concerns
  • The affected products include lot numbers 7261973A and 7261974A, with an expiry date of January 31, 2027
  • Parents are advised to stop using the medication and report any unusual symptoms in children immediately

Pascal Oparada is a journalist with Legit.ng, covering technology, energy, stocks, investment, and the economy for over a decade.

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public health warning following the recall of nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension in the United States over contamination concerns.

The agency disclosed the development in a statement shared on its official X account, warning Nigerians, healthcare providers and drug distributors to remain vigilant against the affected medication entering the Nigerian market.

NAFDAC Warns parents of a contaminated Ibuprofen
NAFDAC raises alarm over the presence of a contaminated children's drug after 90,000 bottles were recalled in the US. Credit: Novatis
Source: Getty Images

Why the children’s drug was recalled

According to NAFDAC, the recall was initiated by the United States Food and Drug Administration (USFDA) after consumers reported unusual foreign materials inside the medication.

Read also

Nigeria to include VeryDarkMan, others in counterterrorism operations, video emerges

The manufacturer, Strides Pharma Inc., reportedly received complaints about a “gel-like mass” and “black particles” in the oral suspension, prompting an urgent recall.

The affected medicine, Children’s Ibuprofen Oral Suspension USP (100 mg/5 mL), is commonly used to treat fever, headaches, sore throat, toothaches and body pain associated with cold and flu in children.

Health authorities warned that the presence of foreign materials in medicines could affect the product’s safety, quality and effectiveness, potentially putting children at risk.

Details of the affected products

NAFDAC said the recalled products were packaged in four-fluid-ounce (120 mL) bottles and manufactured in India by Strides Pharma Inc. for Taro Pharmaceuticals in the United States.

The agency identified the affected batches as lot numbers 7261973A and 7261974A, both carrying an expiry date of January 31, 2027.

Although the products were distributed only within the United States, NAFDAC said it was taking precautionary measures to ensure they do not enter Nigeria through unofficial supply channels.

Read also

FG's panel exposes unlawful privileges Bobrisky enjoyed in prison, recommends prosecuting VDM

NAFDAC intensifies surveillance nationwide

As part of its response, NAFDAC said all zonal directors and state coordinators across the country had been directed to strengthen surveillance and monitor pharmaceutical outlets for the recalled products.

The agency also warned importers, distributors, retailers and healthcare professionals against importing, selling or distributing the affected medicine.

Hospitals, pharmacies and healthcare facilities were advised to immediately inspect their inventories and isolate any suspected batches discovered during routine checks.

Advice to parents and caregivers

NAFDAC urged parents and caregivers who may already have the affected medication to stop using it immediately.

The agency advised that children who may have consumed the medicine and later show unusual symptoms or reactions should be taken for medical evaluation without delay.

Healthcare professionals and members of the public were also encouraged to report any adverse drug reactions or suspicious products through NAFDAC’s official reporting channels or the nearest agency office.

Commitment to public safety

Read also

92 million MTN subscribers still stranded as FCCPC moves on from airtime credit crisis

NAFDAC reaffirmed its commitment to protecting public health through continuous monitoring and regulation of medicines circulating within the country.

NAFDAC raises alarm over contaminated Children's Ibuprofen
Mojisola Adeyeye-led NAFDAC alerts Nigerian parents of contaminated Children's Ibuprofen in the US. Credit: VCG / Contributor/Contributor
Source: Getty Images

The agency noted that proactive alerts and swift regulatory actions remain critical in preventing unsafe pharmaceutical products from reaching Nigerian consumers, especially vulnerable children.

NAFDAC warns of fake Cerelac products

Legit.ng earlier reported that NAFDAC warned the public about the circulation of counterfeit and unregistered Cerelac Mixed Fruits and Wheat products in Lagos.

In a statement shared on the agency's website on Tuesday, the agency said the alert followed a complaint received by Nestle Nigeria Plc, the authorised marketer of the product in Nigeria.

According to NAFDAC, the complaint involved a suspected counterfeit product purportedly manufactured by Nestlé Spain, bearing Batch Code 308002910.

Proofreading by Funmilayo Aremu, copy editor at Legit.ng.

Source: Legit.ng

Authors:
Pascal Oparada avatar

Pascal Oparada (Business editor) For over a decade, Pascal Oparada has reported on tech, energy, stocks, investment, and the economy. He has worked in many media organizations such as Daily Independent, TheNiche newspaper, and the Nigerian Xpress. He is a 2018 PwC Media Excellence Award winner. Email:pascal.oparada@corp.legit.ng